SCHEMBL23919450

SCHEMBL23919450

Cc1cccc(N(c2ccc3ccc4c(N(c5cccc(C)c5)c5c(C)ccc6c5oc5ccccc56)ccc5ccc2c3c54)c2c(C)ccc3c2oc2ccccc23)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.33
HPGD P15428 4/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
PGR P06401 1/20 0.32
HSD17B10 Q99714 2/20 0.32
TSHR P16473 2/20 0.32
CYP3A4 P08684 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
MAPT P10636 7/20 0.32
RAB9A P51151 3/20 0.32
NPSR1 Q6W5P4 2/20 0.32
KDM4E B2RXH2 2/20 0.32
BLM P54132 1/20 0.32
SIGMAR1 Q99720 1/20 0.32
PPARG P37231 2/20 0.32
RXFP1 Q9HBX9 2/20 0.32
NCOR2 Q9Y618 2/20 0.32
LMNA P02545 2/20 0.31
NR2E3 Q9Y5X4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23919273 0.92 MEN1 (0.32) MEN1KMT2A
SCHEMBL23919424 0.91 PGR (0.33) ALDH1A1HPGDPGRHSD17B10TSHR
SCHEMBL21686945 0.90 PGR (0.35) ALDH1A1HPGDPGRHSD17B10TSHR
SCHEMBL23919423 0.89 CYP1A1 (0.33) ALDH1A1HPGDPGRHSD17B10TSHR
SCHEMBL17036291 0.89 ALOX5 (0.38) MAPTRAB9ANPSR1KDM4EBLM
SCHEMBL23919354 0.89 ALDH1A1 (0.33) ALDH1A1HPGDHSD17B10TSHRCYP3A4
SCHEMBL12206523 0.88 ALDH1A1 (0.34) ALDH1A1HPGDSMN1; SMN2PGRHSD17B10
SCHEMBL23919451 0.88 PGR (0.34) ALDH1A1HPGDSMN1; SMN2PGRHSD17B10
SCHEMBL23919268 0.88 ALDH1A1 (0.37) ALDH1A1HPGDSMN1; SMN2PGRHSD17B10
SCHEMBL23919498 0.88 KDM4E (0.31) SMN1; SMN2PGRTSHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210320251-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPLIANCE IDEMITSU KOSAN CO.,LTD. (JP) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210320251-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPLIANCE OLA1, TAS2R19, TMEM109 ALDH1A1 541/4885HPGD 4701/4885SMN1; SMN2 2558/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.